Ruben Ulloa Jr., MD

Ruben Ulloa Jr., MD

MD: Keck School of Medicine of the University of Southern California

Hometown: Chicago, IL

Personal Statement: I was drawn to Washington University in St. Louis for its longstanding history of innovation and discovery fueled by research, its culture of collaboration, and clinical breadth and depth in otolaryngology. On interview day, I felt very welcomed and continue to feel welcomed and supported by everyone I have met here.


Undergraduate: Oberlin College, Oberlin, 2016

Medical School: Keck School of Medicine of the University of Southern California, 2023


  • Alpha Omega Alpha (AOA) Honor Medical Society, 2022-2023


  1. Borreli, M., Nasorallhi, T., Ulloa, R., Raskin, J., Ference, E., & Tang, D.M. (2022, June 30). Invasive Fungal Sinusitis During Active COVID-19 Infection.
  2. Castellanos, C.X., Ulloa, R., Kim, C., Tang, LY., Swanson, M., & Kokot, N.C. (2022, June 30). Enhanced Recovery After Surgery: A Narrative Review on Perioperative Pain Levels and Opiate Use Following Free Flap Reconstruction in Patients With Head And Neck Cancer.
  3. Reyes Orozco, F., Ulloa, R., Lin, M., Xepoleas, M., Paoletti, M., Liu, X., & Hur, K. (2022, June 22). Adverse Events Associated with Image-Guided Sinus Navigation in Endoscopic Sinus Surgery: A MAUDE Database Analysis. %200pubmed.
  4. Wu, F., Ulloa, R., Badash, I., & Hur, K. (2022, February 18). Geographic Variation in Otolaryngologist Intranasal Steroid Prescribing Patterns Among Medicare Beneficiaries.
  5. Clark, B.S., Swanson, M., Widjaja, W., Cameron, B., Yu, V., Ershova, K., Wu, F., Vanstrum, E., Ulloa, R., Heng, A., Nurimba, M., Kokot, N., Kocchar, A., Sinha, U.K., Kim, M.P., & Dickerson, S . (2021, Mar). ERAS for Head and Neck Tissue Transfer Reduces Opioid Usage, Peak Pain Scores, and Blood Utilization. Laryngoscope, 131(3), E792-E799.
  6. Castellanos CX, Paoletti M, Ulloa R, Kim C, Fong M, Xepoleas M, Sinha U, Kokot N, Swanson MS. Opioid Sparing Multimodal Analgesia for Transoral Robotic Surgery: Improved Analgesia and Narcotic Use Reduction. OTO Open. 2023 Mar 14;7(1):e17. doi: 10.1002/oto2.17. PMID: 36998552; PMCID: PMC10046737.